Archford Capital Strategies, LLC reported AMBEV S A SPONSORED ADR ISIN#US02319V1035 (ABEV) in 11 quarterly 13F filings from 2025 Q3 through 2026 Q2. Peak portfolio weight reached 0.35% in 2026 Q1. The latest visible filing shows ABEV at 0.22% of the fund.
This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.
This page is designed to answer the real investor question behind a 13F filing: how meaningful was Archford Capital Strategies, LLC's position in AMBEV S A SPONSORED ADR ISIN#US02319V1035, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.
ABEV was reported at 0.22% of portfolio in the most recent visible filing.
Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.
Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.
Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.
As of 2026 Q2 — sorted by position size
These are the practical questions this page is built to answer before you even open the full history table.
Archford Capital Strategies, LLC reported ABEV across 4 quarterly 13F filings, from 2025 Q3 through 2026 Q2.
The largest reported portfolio weight for ABEV was 0.35% in 2026 Q1.
The most recent filing on this page is 2026 Q2, when Archford Capital Strategies, LLC reported 688,742 shares, equal to 0.22% of portfolio, with an estimated market value of $2.2M.
The chart compares Archford Capital Strategies, LLC's quarterly ABEV portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.
Based on 13F filing dates vs. subsequent ABEV price moves, Archford Capital Strategies, LLC correctly timed 3 out of 6 reported position changes (50%). The annualised alpha on ABEV relative to SPY over the holding period was -11.7%.